Abbott Laboratories http://www.alacrastore.com/company-snapshot/Abbott_Laboratories-1000129 Saturday, August 30, 2008 3:33:19 AM 1000129 Abbott Laboratories en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/MW-0001-27671492newstex/MW-0001-27671492xml FRAMINGHAM, MA, Aug. ##, #### (Marketwire delivered by Newstex) -- FRAMINGHAM, MA -- (Marketwire) -- ##/##/## -- Computerworld, the Voice of IT Management, today announced ## Finalists for its annual "Best Practices in Business Intelligence"...0100000001026000010260010400000004017000040170028/26/2008 11:20:46 AM180000001800200018006000180050001900000019001000190010551900101019001046190010321900200019002007MarketwireMW-0001-27671492ABBOTT LABORATORIESMARRIOTT INTERNATIONAL INCABTMARNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-27572564newstex/BW-0001-27572564xml Aug. ##, #### (Business Wire) -- Four free stock picks are being made available today on Zacks.com. The industrya€™s leading independent research firm highlights one Zacks ## Rank Strong Buy or a Zacks ## Rank Buy stock for each of...040000000400900004016000040160010401604804016018040020000400200607000000070030000700300107014000070140128/21/2008 3:22:12 PM180000001800400018008000Business WireBW-0001-27572564ABBOTT LABORATORIESALMOST FAMILY INCDRESSER-RAND GROUP INC.UNIFIRST CORPABTAFAMDRCUNFNewsNewstexhttp://www.alacrastore.com/storecontent/spcred/663625spcred/663625normThe latest Full Report from S&Pglobal8/6/2008 10:30:00 AM400Full Report663625United StatesPharmaceuticalsAsiaEurope, Middle East, AfricaUnited StatesGlobal IssuersFinancial InstitutionsCorporationsHealth CareFull ReportWell-established positions in a broad range of health care markets; Accelerating pace of new drug launches; and Conservative financial policies. Willingness to aggressively pursue acquisitions to bolster the business portfolio. The strong investment-grade rating on Abbott Park, Ill.-based Abbott Laboratories reflects the company's solid positions in a number of diverse health care segments, its strong financial profile, and its robust discretionary cash flow. Abbott continues to maintain a broad product portfolio with solid positions in various health care segments, including pharmaceuticals, nutritionals, diagnostics, and vascular devices. The excellent business profile considers the pharmaceutical segment as a key element. It continues to account for a majority of Abbott's earnings and cash flows. The success and diversity of this franchise is illustratedUSA00282A00282B00282400282F00282D00282C00281935202010 352020 3520 35Abbott Laboratories100009ASIAEUROMIDAFRUSAABTFULLGLOBISSFICORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/663627spcred/663627normThe latest Summary from S&Pglobal8/6/2008 10:30:00 AM175Summary663627United StatesPharmaceuticalsAsiaEurope, Middle East, AfricaUnited StatesGlobal IssuersFinancial InstitutionsCorporationsHealth CareSummaryThe strong investment-grade rating on Abbott Park, Ill.-based Abbott Laboratories reflects the company's solid positions in a number of diverse health care segments, its strong financial profile, and its robust discretionary cash flow. Abbott continues to maintain a broad product portfolio with solid positions in various health care segments, including pharmaceuticals, nutritionals, diagnostics, and vascular devices. The excellent business profile considers the pharmaceutical segment as a key element. It continues to account for a majority of Abbott's earnings and cash flows. The success and diversity of this franchise is illustrated by the relatively small aggregate sales contribution (29%) of its top four products, which generated $8.0 billion during the period ended March 31, 2008. Pharmaceutical growth is led by theUSA00282A00282B00282400282F00282D00282C00281935202010 352020 3520 35Abbott Laboratories100009ASIAEUROMIDAFRUSAABTSUMMARYGLOBISSFICORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/fitch/428176_pr_framefitch/428176_pr_framehtmlFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Abbott Laboratories803613728/4/2008 2:16:00 PM01030000010317000103170385Press ReleaseABT428176_pr_frameCredit & Investment ResearchFitchResearchhttp://www.alacrastore.com/storecontent/newstex/BW-0001-26905086newstex/BW-0001-26905086xml Jul. ##, #### (Business Wire) -- Four free stock picks are being made available today on Zacks.com. The industrya€™s leading independent research firm highlights one Zacks ## Rank Strong Buy or a Zacks ## Rank Buy stock for each of...0400000004009000040020000400200604016000040160180401604807000000070030000700300107014000070140127/24/2008 3:22:56 PM180000001800400018008000Business WireBW-0001-26905086ABBOTT LABORATORIESCHILDRENS PLACE RETAIL STORES INCPOSCOST JUDE MEDICAL INCABTPKXPLCESTJNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1813510ccbn/T1813510norm...Welcome to Abbott's first quarter #### earnings conference call. (OPERATOR INSTRUCTIONS) This call is being recorded by Abbott. With the exception of any participants questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is material copyrighted by Abbott. It cannot be recorded or rebroadcast without Abbott's expressed written permission. I would now like to introduce Mr. John Thomas, Vice President Investor Relations. ... 7/16/2008 4:55:30 PMAbbott Laboratories54.0000Q1 2008 Abbott Earnings Conference CallABT9:00AM ETTranscriptT1813510Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1813510ccbn/B1813510norm...Received approval for five key new products or indications with collectively significant growth potential. ... 7/16/2008 4:55:25 PMAbbott Laboratories54.0000Q1 2008 Abbott Earnings Conference CallABT9:00AM ETBriefB1813510Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1888881ccbn/B1888881norm...Higher than forecasted other income, reflecting higher ongoing payments from Takeda following conclusion of the TAP JV. ... 7/16/2008 1:05:00 PMAbbott54.0000EditedQ2 2008 Abbott Earnings Conference Call SummaryABT8:00am CTBriefB1888881Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1888881ccbn/T1888881norm...Good morning and thank you for standing by. Welcome to Abbott's second quarter #### earnings conference call. All participants will be able to listen-only until the question-and-answer portion of this call. (OPERATOR INSTRUCTIONS). Should you become disconnected throughout this conference call, please dial #-(###)-###-#### and reference the Abbott call. This call is being recorded by Abbott. With the exception of any participants' questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is material copyrighted by Abbott. It cannot be recorded or rebroadcast without Abbott's expressed written permission. I would now like to introduce, Mr. John Thomas, Vice President, Investor Relations Sir, you may begin. ... 7/16/2008 10:05:00 AMAbbott54.0000FinalQ2 2008 Abbott Earnings Conference Call TranscriptABT8:00am CTTranscriptT1888881Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-26696985newstex/PRN-0005-26696985xml Jul. ##, #### (PR Newswire delivered by Newstex) -- ABBOTT PARK, Ill., July ## /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June ##, ####. * Diluted earnings per share,...07000000070050000701400007014012070140090701401407014002070030000700300104000000040020000400200604016000040160180401601304016048040160010401604713000000130010001300100213010000130100051600000016003000160030037/16/2008 8:18:02 AM180000001800400018023000180080001801500018022000180200001801200018016000190000001900100019001031PR Newswire USPRN-0005-26696985ABBOTT LABORATORIESMILES D WHITEABTNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-26333144newstex/PRN-0005-26333144xml Jun. ##, #### (PR Newswire delivered by Newstex) -- ABBOTT PARK, Ill., June ## /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) will announce its #### second-quarter financial results on Wednesday, July ##, ####, before the market opens.The...07000000070140000701401204000000040160000401604804016018040160016/30/2008 9:21:09 AM180000001800800018004000PR Newswire USPRN-0005-26333144ABBOTT LABORATORIESABTNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1864075ccbn/T1864075norm... - Goldman Sachs - AnalystOkay, we're going to get started. Welcome back everybody from launch. It is my pleasure to introduce Abbott. And we've really got a terrific contingent of management here today. So certainly there should be a lot of opportunities to direct questions at different aspects of the business. Standing up at the podium is Tom Freyman, the Company's Chief Financial Officer. To Tom's immediate right is Mary Szela, who is the Senior Vice President of Pharmaceutical Operations. John Capek next to her, who is EVP Medical Devices and oversees the XIENCE program, as you know came from Guidant. And John Thomas to my immediate left who is the Vice President of Investor Relations. So why don't we get started, Tom, and then we can kick it into some Q&A. ... 6/10/2008 7:04:00 PMAbbott54.0000FinalAbbott at Goldman Sachs Healthcare Conference TranscriptABT3:20pm CTTranscriptT1864075Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/fitch/423081_pr_framefitch/423081_pr_framehtmlFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Abbott LaboratoriesAstraZeneca plcBayer AGFresenius SEGlaxoSmithKline plcMerck & Company, Inc.Novartis AGPfizer Inc.Roche Deutschland Holding GmbHSanofi-Aventis S.A.Wyeth8009174080360516803613728036159280361630803624348045797280457976804579798045798382151338858840736/9/2008 2:13:00 PM010000000103000001031700010317030104000085Press ReleaseABTAZNBAYFREGSKMRKNOVNPFESANWYE423081_pr_frameCredit & Investment ResearchFitchResearchhttp://www.alacrastore.com/storecontent/fitch/388942_report_framefitch/388942_report_framepdfFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Abbott LaboratoriesAmgen, Inc.AstraZeneca plcBristol-Myers Squibb CompanyEli Lilly & CompanyGlaxoSmithKline plcJohnson & JohnsonMerck & Company, Inc.Novartis AGPfizer Inc.Roche Deutschland Holding GmbHSanofi-Aventis S.A.Schering-Plough CorporationWyeth800917408036051680361372803614198036159280361630803624348041717980457972804579768045797980457983806562368071041080843884850944736/9/2008 10:11:00 AM0100000001030000010317000103170301040000275Special ReportABTAMGNAZNBMYGSKJNJLLYMRKNOVNPFESANSGPWYE388942_report_frameCredit & Investment ResearchFitchResearchhttp://www.alacrastore.com/storecontent/ccbn/T1845955ccbn/T1845955norm... - Abbott - EVP Finance, CFO Thanks a lot, Matt, for that introduction. And good morning everyone. Before we begin please take a moment to review our forward-looking statement which is noted on the second slide. Today I will provide an overview of Abbott's diverse business portfolio, highlighting how we are unique among our health care peers. As we discussed on our first quarter earnings conference call, in #### we expect to deliver an accelerating double-digit EPS growth. This follows our #### results for growth in ongoing earnings per share was more than ##%. We are off to a strong start this year, delivering double-digit sales and earnings growth in the first quarter ahead of our original expectation. We have already accomplished a number of strategic objectives this year as we successfully concluded the TAP Joint Venture, presented compelling long-term data for Xience, and received approvals for several key new products or indications. In general, our businesses are healthy and we... 5/22/2008 3:05:00 PMAbbott54.0000FinalAbbott at Citigroup Healthcare Conference TranscriptABT7:00am CTTranscriptT1845955Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1845985ccbn/B1845985norm...Pleased with long-term safety and efficacy data from #,###-patient US pivotal drug-eluting stent trial SPIRIT III.www.streetevents.comContact Us ... 5/13/2008 2:06:00 PMAbbott54.0000EditedXience SPIRIT III Data Review SummaryABT11:00am CTBriefB1845985Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1845985ccbn/T1845985norm...Good morning. Welcome to the special Abbott conference call. (OPERATOR INSTRUCTIONS) This call is being recorded by Abbott. With the exception of any participants' questions asked during the question and answer session, the entire call, including the question and answer session, is material copyrighted by Abbott. It cannot be recorded or rebroadcast without Abbott's express written permission. I would now like to introduce Mr. John Thomas, Vice President of Investor Relations for Abbott. Sir, you may begin.... 5/13/2008 2:06:00 PMAbbott54.0000FinalXience SPIRIT III Data Review TranscriptABT11:00am CTTranscriptT1845985Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/moodys/PR_154747_9000moodys/PR_154747_9000htmlGlobal Credit Research Rating Action # MAY #### Rating Action: Abbott Laboratories Moody's changes Abbott's rating outlook to stable from negative Senior notes at A# New York, May ##, #### -- Moody's Investors Service changed the rating...5/6/2008 12:33:07 AMhtmlAbbott LaboratoriesAbbott Japan Co., Ltd.Abbott Japan Co., Ltd.; Abbott Laboratories9000806793858150.0000NewsRating ActionPR_154747_9000Credit & Investment ResearchMoody's Global Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/T1816617ccbn/T1816617norm... - Morgan Stanley - AnalystOkay. Good morning, everyone. Let's get started. I'm Glenn Reicin from Morgan Stanley. With me is David Roman from Morgan Stanley. I have Tom Freyman, CFO of Abbott Labs, and John Thomas, who's VP of Investor Relations. I hope I got all the titles right.... 4/30/2008 5:07:00 PMAbbott54.0000FinalAbbott at Morgan Stanley 2008 Global Healthcare Unplugged Conference TranscriptABT8:30am ETTranscriptT1816617Credit & Investment ResearchThomson Street Events